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48. Can early 24 hours Holter monitoring predict
obstructive coronary artery lesions in patients wi-
th low risk acute coronary syndrome?
T. Taha
Minia University, minia, Egypt
Identification of patients at increased risk of death due
to acute coronary syndrome (ACS) can add to risk stratifi-
cation and guide the next step in themanagement of those
patients. Altered HRV has been associated with adverse
outcomes in heart disease, but this has not been estab-
lished in patients with acute chest pain.This study aimed
to create a non-invasive, economical and risk-free method
in the clinical evaluation and diagnosis of significant CAD
among patients with unstable angina.Twenty-four-hour
Holter recordings of 100 patients with ACS were initiated
within 24 hours of admission at the emergency depart-
ment; stress ECG was done for all patients while coronary
angiography was done only for patients with abnormal
stress test. Time domain, frequency domain, and non-
linear HRV were examined.The mean SDNN was statisti-
cally significantly lower in patients with abnormal stress
test, many time and frequency domain HRV parameters
was statistically lower in patients with significant coronary
arteries obstruction.HRVmeasured close to theACSonset
may assist in risk stratification. HRV parameters may pro-
vide additional, incremental prognostic information to
established assessment guidelines and possible early
intervention in those patients.
http://dx.doi:10.1016/j.jsha.2016.04.049
TREATMENT OF ARRHYTHMIAS: ABLATION
49. Impact of atrial fibrillation on platelet-
predominate gene expression
W. Wysokinski
Mayo Clinic, Rochester, USA
Platelets retain cytoplasmic mRNA and are capable of
protein biosynthesis upon stimulation. We hypothesized
that changes in flow hemodynamics, and extracel- lular
matrix stimulation induced by non-valvular atrial fibrilla-
tion (NVAF) may impact platelet RNA content and there-
fore platelet activity in patients with this dysrhythmia.
Expression of platelet predominate genes was assessed in
consecutive NVAF patients before and 3–4 months after
catheter ablation of pulmonary veins (CAPV). Results were
compared to age and gendermatchednormal sinus rhythm
(NSR) controls. RNA from isolated platelets were reverse-
transcribed (Invitrogen), assayed against 22 genes (Taq-
Man) using real-time qPCR, and expressed as mean cycle
threshold (DCt) (ABI Prism 7700 Sequence Detection Sys-
tem) using beta-2-microglobulin as endogenous control.
All evaluated genes, except cathepsin A gene (CTSA),
showed lower expression (higher DCt) in 103 NVAF
patients compared to 55 NSR controls. At least 2-fold lower
expression was found in 12 genes. Within this group,
expression of insulin-like growth factor binding protein
acid labile subunit gene (IGFALS) was more than 16th fold
lower (more than four cycles; 17.0 ± 2.8 vs 12.5 ± 3.8,
p < .001) and non-muscle cofilin gene (CFL1), prostacyclin
receptor gene (PTGIR), and von Willebrand gene (VWF)
were 4-fold lower compared to NSR controls. After CAPV,
7 genes demonstrated increased expression including
IGFALS gene that showed 256-fold increase (8.3 ± 5.6 vs
16.6 ± 3.0, p < .001). Four genes had lower expression after
CAPV but only one, tubulin gene (TUBA4A) had it lower
by one cycle (2-fold). DD96 membrane associated protein
gene (PDZK1IP) showed significantly higher expression in
patients without recurrence of atrial fibrillation compared
to those with confirmed or suspected recurrence.The
altered flow hemodynamics associated with NVAF impacts
platelet RNA content. Of these, measurable differences of
IGFALS expression is notable. Changes of platelet gene
expression following sinus rhythm restoration underscores
the direct interaction between these two entities.
http://dx.doi:10.1016/j.jsha.2016.04.050
Intervention and surgery
CATHETER-BASED CORONARY INTERVENTIONS: EXPERI-
MENTAL NEW TECHNOLOGY
50. Primary PCI for STEMI patients at KACC: Has
patient’s access and hospital outcome improved
over the last 5 years?
B.T. Saeed a, A. Salih b, N. Enriquez b, K. Ayoub b,
M. Balghith b, A. Alghamdi b
aKACC, KAMC, NGHA, Riyadh, Saudi
Arabia; bKACC, KAMC, NGHA, Cardiac Sciences,
Riyadh, Saudi Arabia
Primary PCI (pPCI) is Class1 indication to treat patients
(pts) with S-T elevation Myocardial Infarction (STEMI). In
2010, 56%of STEMIpts presented toKACCwere treatedwith
pPCI with hospital mortality of 2.3% compared to 11.3% for
those who did not qualify mainly due to late presentation.
We aim to compare pts access, reason for no access to pPCI
and hospital outcome 5 yrs on. Data from 2010 at KACC
showed relatively low access to pPCI for STEMI pts primarily
due to late presentation and initial thrombolysis. We believe
that pts access to pPCI would have improved over the last 5
years due to improved public awareness and expanding
evidenced-based health provision. This is a retrospective
study to analyze and compare data for STEMI pts during
2010 (G1 = 223 pts) and those treated between August 2014
and August 2015 (G2 = 288 pts). We compared demographic
and baseline characteristics, pts access, reason for no access
and hospital mortality for the two groups. We used
student-t test to compare continuous variables and Chi-
square test to compare categorical onesOf the 288 pts in G2,
247 pts (85%) were males with average age of 57 yrs. 49%
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were diabetics, 48% hypertensive, 48% were smokers and
27% were obese. These were not different in G1. Of G2, 164
pts (57%) only had access to pPCI compared to 56% in G1
(p = 0.536-NS). In G2, the main reasons for no pPCI was late
presentation in 47% vs 53% in G1; P = 0.34-NS and 27% due
to thrombolysis vs 17% in G1 (p = 0.11NS). Hospital mortality
in G2was 4% in those treatedwith pPCI compared to 2.3% in
G1 (P = 0.522-NS). Mortality In pts who did not receive pPCI
in G2 was 8% compared to 11.3% in G1 (p = 0.49-NS).
Females in G2 has about 3 times higher mortality. Compared
to 2010, pts treated for STEMI in the last 12 months at KACC
still have same, relatively low access to pPCI due mainly to
persistent pattern of late presentation and prior thrombolysis
which reflect apparent lack of direct access to hospitals with
pPCI facilities. This seemingly relates to both lack of public
awareness and health provision factors in pPCI organiza-
tions. Hospital mortality rate for pts treated with pPCI
remained low during the two era while pts who did not qua-
lify for pPCI showed a trend towards improved survival.
http://dx.doi:10.1016/j.jsha.2016.04.051
51. Same-day discharge after percutaneous coron-
ary intervention
R. Gul
Prince Sultan Cardiac Center, Qassim, Buraydah, Saudi
Arabia
Due to increasing burden of cardiovascular disease
there is always problem of availability of beds in tertiary
care hospitals. To manage this problem we need a
strategy which shorten patients stay in the hospital. This
study evaluate the safety of the same day discharge after
uncomplicated PCI for patients with stable coronary
artery disease who are admitted electively to day cath
unit. This study sought to assess the safety of same-day
discharge in patients undergoing percutaneous coronary
intervention (PCI). We conducted a prospective observa-
tional study, reporting outcomes of patients discharged
on the same day after elective uncomplicated PCI.
Patients were admitted in day cath unit with a diagnosis
of stable angina and patients for planned elective PCI.
Demographic data, procedural characteristics, and
adverse outcome were collected. A composite end point
include: death, myocardial infarction (MI), stroke, major
bleeding, target lesion revascularization and vascular
complications. 77 patients were included in the study.
All patients had uncomplicated PCI. Majority 90% of
PCI was through radial approach. Post PCI patients were
observed in day cath unit for an average time of 6 h and
then were discharged. Patients were clearly instructed, in
case of any adverse events to approach to ER and to con-
sult the interventionist also the patients were follow up
on phone call at 24 h and 72 h post procedure and then
seen in OPD at one month. There was no death, myocar-
dial infarction, TLR or TVR. There was no major or minor
bleeding and there was no vascular complications. Same
discharge after uncomplicated elective PCI in stable,
selected groups of patients with close follow up is safe
and feasible, However further large RCTs are needed to
confirm the safety and feasibility of the same discharge.
http://dx.doi:10.1016/j.jsha.2016.04.052
MYOCARDIAL PROTECTION, INTRAOPERATIVE MAN-
AGEMENT, AND POSTOPERATIVE CRITICAL CARE
52. Early revascularization on veno-arterial ECMO
for patients with cardiogenic shock post stemi
K. Alkhamees a, M. Alrefaei b, S. alnosiry c, F.
Oueida d, J. najeeb e, K. Eskander d
a Saud Al-babtain Cardaic Center, Dammam, Saudi
Arabia; bSaud Al-babtain Cardaic Center, Cardiology,
Dammam, Saudi Arabia; c Saud Al-babtain Cardaic
Center, Anaesthesia, Dammam, Saudi Arabia; d Saud
Al-babtain Cardaic Center, Cardiac Surgery, Dammam,
Saudi Arabia; e Saud Al-babtain Cardaic Center, Car-
diac Intervention, Dammam, Saudi Arabia
Refractory Cardiogenic shock (CS) complicates 5–7% of
cases of ST-elevation myocardial infarction (STEMI), and
is a leading cause of hospital death after myocardial
infarction. CS complicating acute myocardial infarction
continues to have a highmortality of 60–80% despite early
revascularization and adjunctive therapies. We studied
the effectiveness of veno-arterial (VA) – Extracorporeal
Membrane Oxygenator (ECMO) for the patients with
CS post STEMI during coronary angiography at our insti-
tute. Between January 2014 to April 2015, 8 male patients
who suffered from progressive severe refractory CS post
STEMI underwent emergent peripheral VA-ECMO
implantation while performing cardiopulmonary resusci-
tation during coronary angiography. 7 patients of under-
went PCI, while 1 patient was not amenable to PCI or
CABG. The mean duration of support was 8.5  5.8 days.
6 patients were successfully weaned from ECMO. While
on ECMO support, 2 patients died. Mean EF after ECMO
explantation was 32.5%  10.5%. The 30-day survival was
50%. Early revascularization on ECMO allows supporting
hemodynamic efficiently in cardiogenic shock patients.
http://dx.doi:10.1016/j.jsha.2016.04.053
PERCUTANEOUS NON-CORONARY CARDIAC INTERVEN-
TION (INCLUDING PERCUTANEOUS VALVES)
53. Bilateral ductal stenting for nonconfluent
pulmonary arteries in a newborn
K. Al Dhahri a, V. Arulselvam b, D. Khaymaf a
a Saud Al-Babtain Cardiac Centre, Pediatric Cardiology,
Dammam, Saudi Arabia; bSaud Al-Babtain Cardiac
Centre, Dammam, Saudi Arabia
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